[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

Upper tract urothelial carcinoma is a rare disease entity with complex diagnostic and treatment options. In the Swedish National Quality Register for Bladder and Urinary Tract Cancer (SNRUBC), prospective registration of tumour and treatment characteristics is performed with high coverage, where data including quality indicators are presented online (RODRET). Between 2023 and 2024 regional differences in the majority of quality indicators are observed in the SNRUBC, with target levels only met in a few regions. For some quality indicators, such as proportion of patients referred to multidisciplinary tumour board discussion or proportion receiving curative treatment and perioperative lymphadenectomy, an association with better performance and hospital volume above 10 patients per year was observed. A regional centralization of multidisciplinary tumour boards for these patients might decrease regional inequalities and improve quality metrics.